Autor/es reacciones

Quique Bassat

Director General and ICREA Research Professor at the Barcelona Institute for Global Health (ISGlobal)

The approval by the MHRA of a new vaccine from Moderna that protects against the Omicron variant is excellent news, given that this will allow the original vaccine, based on the original Wuhan variant, to be replaced by a vaccine that protects against a variant much closer to the one that now predominates, not only in the UK, but in much of the world.  

This new generation of vaccines will allow more realistic protection against severe disease and possibly infection, and will be a quantum leap in our containment of ongoing transmission.

EN